N-protein vaccine is effective against COVID-19: Phase 3, randomized, double-blind, placebo-controlled clinical trial von Rabdano, Sevastyan O., Ruzanova, Ellina A., Vertyachikh, Anastasiya E., Teplykh, Valeriya A., Emelyanova, Alla B., Rudakov, German O., Arakelov, Sergei A., Pletyukhina, Iuliia V., Saveliev, Nikita S., Lukovenko, Anna A., Fakhretdinova, Liliya N., Safi, Ariana S., Zhirenkina, Ekaterina N., Polyakova, Irina N., Belozerova, Natalia S., Klykov, Vladislav V., Savelieva, Arina P., Ekimov, Aleksey A., Pokachalov, Konstantin V., Merkulov, Vadim A., Yudin, Sergei M., Kruchko, Daria S., Berzin, Igor A., Skvortsova, Veronika I.

Volltext

Safety and Immunogenicity of the Convacell ® Recombinant N Protein COVID-19 Vaccine von Rabdano, Sevastyan, Ruzanova, Ellina, Makarov, Denis, Vertyachikh, Anastasiya, Teplykh, Valeriya, Rudakov, German, Pletyukhina, Iuliia, Saveliev, Nikita, Zakharov, Konstantin, Alpenidze, Diana, Vasilyuk, Vasiliy, Arakelov, Sergei, Skvortsova, Veronika

Volltext